Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Akero Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 240
- +51 vs. Q4 2024
- Shares held
- 86.4M
- +12.4M (+16.8%) vs. Q4 2024
- Total value
- $3.50B
- +$1.45B (+70.2%) vs. Q4 2024
- New holders
- 77
- 91 more added
- Sold out
- 26
- 49 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Standard Life Aberdeen plc | 406,700 | $16.5M | 0.03% | +136,918+50.8% | Added |
| EcoR1 Capital, LLC | 440,000 | $17.8M | 1.06% | +440,000 | New |
| Woodline Partners LP | 480,736 | $19.5M | 0.13% | +100,769+26.5% | Added |
| Goldman Sachs Group Inc | 488,392 | $19.8M | 0.00% | +30,868+6.7% | Added |
| Loomis Sayles & Co L P | 488,938 | $19.8M | 0.03% | +488,938 | New |
| Voloridge Investment Management, LLC | 501,485 | $20.3M | 0.08% | +501,485 | New |
| Point72 Asset Management, L.P. | 508,340 | $20.6M | 0.06% | −391,340−43.5% | Reduced |
| Sofinnova Investments, Inc. | 510,020 | $20.6M | 1.56% | +510,020 | New |
| Fred Alger Management, LLC | 515,324 | $20.9M | 0.12% | +251,971+95.7% | Added |
| Dimensional Fund Advisors LP | 526,642 | $21.3M | 0.01% | +77,532+17.3% | Added |
| Lord, Abbett & Co. LLC | 527,004 | $21.3M | 0.08% | +527,004 | New |
| Baker Bros. Advisors LP | 548,713 | $22.2M | 0.25% | −548,369−50.0% | Reduced |
| Summit Partners Public Asset Management, LLC | 580,000 | $23.5M | 1.13% | +580,000 | New |
| Charles Schwab Investment Management Inc | 582,254 | $23.6M | 0.00% | +41,562+7.7% | Added |
| Northern Trust Corp | 656,733 | $26.6M | 0.00% | +36,412+5.9% | Added |
| Rock Springs Capital Management LP | 672,759 | $27.2M | 1.56% | −273,740−28.9% | Reduced |
| Silverarc Capital Management, LLC | 719,992 | $29.1M | 6.09% | −19,571−2.6% | Reduced |
| Long Focus Capital Management, LLC | 729,504 | $29.5M | 2.01% | +9,900+1.4% | Added |
| Perceptive Advisors LLC | 792,960 | $32.1M | 1.14% | −392,632−33.1% | Reduced |
| Morgan Stanley | 802,854 | $32.5M | 0.00% | +331,319+70.3% | Added |
| Redmile Group, LLC | 939,277 | $38.0M | 3.59% | −295,932−24.0% | Reduced |
| FMR LLC | 1,009,127 | $40.8M | 0.00% | +970,403+2,505.9% | Added |
| SG Americas Securities, LLC | 1,155,787 | $46.8M | 0.16% | +557,794+93.3% | Added |
| Logos Global Management LP | 1,200,000 | $48.6M | 8.64% | +400,000+50.0% | Added |
| Bellevue Group AG | 1,250,666 | $50.6M | 1.13% | +1,250,666 | New |
| Alliancebernstein L.P. | 1,251,369 | $50.7M | 0.02% | −587,912−32.0% | Reduced |
| Alkeon Capital Management LLC | 1,550,934 | $62.8M | 0.37% | −210,334−11.9% | Reduced |
| Marshall Wace, LLP | 1,607,842 | $65.1M | 0.09% | +1,332,768+484.5% | Added |
| Geode Capital Management, LLC | 1,749,194 | $70.8M | 0.01% | +189,563+12.2% | Added |
| Citadel Advisors LLC | 1,909,330 | $77.3M | 0.08% | +554,437+40.9% | Added |
| UBS Group AG | 2,156,406 | $87.3M | 0.02% | +1,784,562+479.9% | Added |
| State Street Corp | 2,494,743 | $101.0M | 0.00% | +158,799+6.8% | Added |
| Deep Track Capital, LP | 3,210,270 | $130.0M | 4.21% | +1,720,270+115.5% | Added |
| Vanguard Group Inc | 4,230,644 | $171.3M | 0.00% | +526,233+14.2% | Added |
| Price T Rowe Associates Inc | 4,817,091 | $195.0M | 0.02% | +495,119+11.5% | Added |
| General Atlantic LLC | 5,233,989 | $211.9M | 7.11% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,936,240 | $240.3M | 0.05% | −1,440,721−19.5% | Reduced |
| BlackRock, Inc. | 6,255,024 | $253.2M | 0.01% | +330,841+5.6% | Added |
| RTW Investments, LP | 7,419,340 | $300.3M | 4.59% | +559,517+8.2% | Added |
| Janus Henderson Group PLC | 7,068,648 | $301.9M | 0.17% | +1,034,409+17.1% | Added |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −670,048−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −649,134−100.0% | Sold out |
| Pfizer Inc | 0 | $0 | 0.00% | −562,626−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −460,617−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| Great Lakes Advisors, LLC | 0 | $0 | 0.00% | −193,384−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −67,964−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −41,100−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,854−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −9,879−100.0% | Sold out |
| Quattro Financial Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −8,950−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −8,336−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −2,950−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,848−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −2,449−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −390−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| WPG Advisers, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |